Education
About Us
Working with TipRanks
Follow Us
Innovation Pharmaceuticals Inc (IPIX)
OTHER OTC:IPIX
IPIX Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.02
Previous CloseN/A
Volume37.05K
Average Volume (3M)600.25K
Market Cap
$104.14K
Enterprise ValueN/A
Total Cash (Recent Filing)$748.00K
Total Debt (Recent Filing)$2.02M
Price to Earnings (P/E)―
Beta-7.25
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding514,013,730
10 Day Avg. Volume675,361
30 Day Avg. Volume600,251
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Innovation Pharmaceuticals News
PremiumCompany Announcements
Innovation Pharmaceuticals Inc Faces Lease Litigation Loss
PremiumCompany Announcements
Innovation Pharmaceuticals Announces Board Members’ Resignation
---
Ownership Overview
―
Insiders
0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
IPIX FAQ
What was Innovation Pharmaceuticals Inc’s price range in the past 12 months?
Innovation Pharmaceuticals Inc lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.
What is Innovation Pharmaceuticals Inc’s market cap?
Innovation Pharmaceuticals Inc’s market cap is $104.14K.
When is Innovation Pharmaceuticals Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Innovation Pharmaceuticals Inc’s earnings last quarter?
Innovation Pharmaceuticals Inc released its earnings results on May 10, 2018. The company reported -$0.02 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.02.
Is Innovation Pharmaceuticals Inc overvalued?
According to Wall Street analysts Innovation Pharmaceuticals Inc’s price is currently Overvalued.
Does Innovation Pharmaceuticals Inc pay dividends?
Innovation Pharmaceuticals Inc does not currently pay dividends.
What is Innovation Pharmaceuticals Inc’s EPS estimate?
Innovation Pharmaceuticals Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Innovation Pharmaceuticals Inc have?
Innovation Pharmaceuticals Inc has 514,013,730 shares outstanding.
What happened to Innovation Pharmaceuticals Inc’s price movement after its last earnings report?
Innovation Pharmaceuticals Inc reported an EPS of -$0.02 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Innovation Pharmaceuticals Inc?
Currently, no hedge funds are holding shares in IPIX
---
Company Description
Innovation Pharmaceuticals Inc
Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Its lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19. The company is also developing Kevetrin, an anti-cancer compound for treating ovarian cancer. It has a license agreement with Alfasigma S.p.A.; and collaborative research agreement with Fox Chase Chemical Diversity Center, Inc. The company was formerly known as Cellceutix Corporation and changed its name to Innovation Pharmaceuticals Inc. in June 2017. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts.
---
Bioline RX Ltd Sponsored ADR
―
Soligenix
―
CytoDyn
―
Bioxcel Therapeutics
―
Atea Pharmaceuticals
―
---